🚀 VC round data is live in beta, check it out!
Bioceres Valuation Multiples
Discover revenue and EBITDA valuation multiples for Bioceres and similar public comparables like Sapmer, Proximar Seafood, Carbochim, Copeval and more.
Bioceres Overview
About Bioceres
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
Founded
2017
HQ
Employees
751
Website
Financials (LTM)
EV
$277M
Bioceres Financials
Bioceres reported last 12-month revenue of $335M and EBITDA of $24M.
In the same LTM period, Bioceres generated $132M in gross profit, $24M in EBITDA, and had net loss of ($52M).
Revenue (LTM)
Bioceres P&L
In the most recent fiscal year, Bioceres reported revenue of $335M and EBITDA of $24M.
Bioceres expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $335M | XXX | $335M | XXX | XXX | XXX |
| Gross Profit | $132M | XXX | $128M | XXX | XXX | XXX |
| Gross Margin | 39% | XXX | 38% | XXX | XXX | XXX |
| EBITDA | $24M | XXX | $24M | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| EBIT Margin | (1%) | XXX | (0%) | XXX | XXX | XXX |
| Net Profit | ($52M) | XXX | ($52M) | XXX | XXX | XXX |
| Net Margin | (15%) | XXX | (15%) | XXX | XXX | XXX |
| Net Debt | — | — | $228M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Bioceres Stock Performance
Bioceres has current market cap of $35M, and enterprise value of $277M.
Market Cap Evolution
Bioceres' stock price is $0.56.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $277M | $35M | 0.0% | XXX | XXX | XXX | $-0.82 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBioceres Valuation Multiples
Bioceres trades at 0.8x EV/Revenue multiple, and 11.5x EV/EBITDA.
EV / Revenue (LTM)
Bioceres Financial Valuation Multiples
As of March 7, 2026, Bioceres has market cap of $35M and EV of $277M.
Equity research analysts estimate Bioceres' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Bioceres has a P/E ratio of (0.7x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $35M | XXX | $35M | XXX | XXX | XXX |
| EV (current) | $277M | XXX | $277M | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 11.5x | XXX | 11.5x | XXX | XXX | XXX |
| EV/EBIT | (75.9x) | XXX | (363.8x) | XXX | XXX | XXX |
| EV/Gross Profit | 2.1x | XXX | 2.2x | XXX | XXX | XXX |
| P/E | (0.7x) | XXX | (0.7x) | XXX | XXX | XXX |
| EV/FCF | 6.2x | XXX | 6.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Bioceres Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Bioceres Margins & Growth Rates
Bioceres' revenue in the last fiscal year declined by (17%).
Bioceres' revenue per employee in the last FY averaged $0.4M.
Bioceres Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (17%) | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (143%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 22% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 38% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Bioceres Public Comps
See public comps and valuation multiples for other Agriculture and Chemicals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Sapmer | XXX | XXX | XXX | XXX | XXX | XXX |
| Proximar Seafood | XXX | XXX | XXX | XXX | XXX | XXX |
| Carbochim | XXX | XXX | XXX | XXX | XXX | XXX |
| Copeval | XXX | XXX | XXX | XXX | XXX | XXX |
| Cropmate | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Bioceres M&A Activity
Bioceres acquired XXX companies to date.
Last acquisition by Bioceres was on XXXXXXXX, XXXXX. Bioceres acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Bioceres
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBioceres Investment Activity
Bioceres invested in XXX companies to date.
Bioceres made its latest investment on XXXXXXXX, XXXXX. Bioceres invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Bioceres
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Bioceres
| When was Bioceres founded? | Bioceres was founded in 2017. |
| Where is Bioceres headquartered? | Bioceres is headquartered in Argentina. |
| How many employees does Bioceres have? | As of today, Bioceres has over 751 employees. |
| Who is the CEO of Bioceres? | Bioceres' CEO is Federico Trucco. |
| Is Bioceres publicly listed? | Yes, Bioceres is a public company listed on Nasdaq. |
| What is the stock symbol of Bioceres? | Bioceres trades under BIOX ticker. |
| When did Bioceres go public? | Bioceres went public in 2018. |
| Who are competitors of Bioceres? | Bioceres main competitors are Sapmer, Proximar Seafood, Carbochim, Copeval. |
| What is the current market cap of Bioceres? | Bioceres' current market cap is $35M. |
| What is the current revenue of Bioceres? | Bioceres' last 12 months revenue is $335M. |
| What is the current EV/Revenue multiple of Bioceres? | Current revenue multiple of Bioceres is 0.8x. |
| Is Bioceres profitable? | Yes, Bioceres is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Bioceres? | Bioceres' last 12 months EBITDA is $24M. |
| What is Bioceres' EBITDA margin? | Bioceres' last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of Bioceres? | Current EBITDA multiple of Bioceres is 11.5x. |
| What is the current FCF of Bioceres? | Bioceres' last 12 months FCF is $44M. |
| What is Bioceres' FCF margin? | Bioceres' last 12 months FCF margin is 13%. |
| What is the current EV/FCF multiple of Bioceres? | Current FCF multiple of Bioceres is 6.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.